Lead sponsor
Shenzhen Protgen Co., Ltd.
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of November 5, 2026.
1
Trials led
0
Ongoing
30
Total enrollment
5
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Early Phase 1
1
Trials by status
Completed
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Recombinant Human Serum Albumin in the Treatment of Mild-to-moderate AD (Alzheimer's Disease) Exploratory Clinical TrialAlzheimer's diseaseEarly Ph 1Completed30